Article thumbnail

Eriobotrya japonica hydrophilic extract modulates cytokines in normal tissues, in the tumor of Meth-A-fibrosarcoma bearing mice, and enhances their survival time

By Heba A Alshaker, Nidal A Qinna, Fadi Qadan, Mona Bustami and Khalid Z Matalka
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3045389
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). AB: Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.
  2. (2005). Abu Baker Y: Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: Application to lipopolysaccharide-induced differential milieu of cytokines. Neuroendocrinol Lett
  3. (1999). An essential role for NF-κB in IL-18-induced IFN-γ expression in KG-1 cells.
  4. (2006). B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity
  5. (2002). Blankenstein T: Inhibition of methylcholanthrene-induced carcinogenesis by an interferon receptordependent foreign body reaction.
  6. (2002). CA: Regulatory pathways involved in the infectioninduced production of IFN-γ by NK cells. Microbes Infect
  7. (2006). Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol
  8. (2007). CM: Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity? Cytokine Growth Factor Rev
  9. (1999). CR: Distinct dendritic cell subsets differentially regulate the class of immune response in vivo.
  10. (2006). CT: Transforming growth factorbeta induces development of the T(H)17 lineage. Nature
  11. (2007). Cytokine gene transfer for cancer therapy. Cytokine Growth Factor Rev
  12. (2008). Cytokine-producing B lymphocytes - key regulators of immunity. Curr Opin Immunol
  13. (1991). Cytokines and cancer: experimental systems. Curr Opin Immunol
  14. (2006). Egilmez NK: Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors.
  15. (2008). Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide-induced cytokines and inducible enzyme production via the nuclear factor-κB signaling pathway in lung epithelial cells.
  16. (2007). Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol
  17. (2008). GP: Role of innate immune cells and their products in lung immunopathology.
  18. (1997). H: Changes in cellular composition induced by neocarzinostatin pretreatment in Meth Abearing mice and the responsible antitumor effector cells. Immunopharmacology
  19. (1999). Inhibition of transforming growth factorbeta/SMAD signalling by the interferon-gamma/STAT pathway. Nature
  20. (2005). Innate immunity and the lung: defense at the interface between host and environment. Trends Cardiovasc Med
  21. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol
  22. (2006). Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature
  23. (2009). KZ: Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo.
  24. (2009). KZ: Epicatechin suppresses IL-6, IL-8 and enhances IL10 production with NF-κB nuclear translocation in whole blood stimulated system. Neuro Endocrinol Lett
  25. (2009). Liu X: The role of interferon gamma in regulation of CD4 + T-cells and its clinical implications. Cell Immunol
  26. (2008). LM: Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res
  27. (2008). MB: TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol Immunol
  28. (2007). Moustakas A: Actions of TGF-β as tumor suppressor and prometastatic factor in human cancer. Biochim Biophys Acta
  29. (2005). Nishino H: Anti-inflammatory and anti-tumorpromoting effects of the triterpene acids from the leaves of Eriobotrya japonica. Biol Pharm Bull
  30. (2000). Polyphenols from Eriobotrya japonica and their cytotoxicity against human tumor cell lines. Chem Pharm Bull
  31. (2007). Qa’dan F: The differential effect of Eriobotrya japonica hydrophilic leaf extract on cytokines production and modulation. Cytokine
  32. (2007). RA: T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity
  33. (2001). RD: IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature
  34. (2000). Reise Sousa C: CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity
  35. (2009). Reisfeld RA: Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One
  36. (2009). T: Anti-inflammatory effect of leaves of Eriobotrya japonica correlating with attenuation of p38 MAPK, ERK, and NF-κB activation in mast cells. Toxicol in Vitro
  37. (2002). T: Antitumor activity of compounds isolated from leaves of Eriobotrya japonica. J Agric Food Chem
  38. (2007). T: JAK-STAT signaling: from interferons to cytokines.
  39. (2001). Tamura K: Inoculation of human interleukin-17 genetransfected Meth-A fibrosarcoma cells induces T cell-dependent tumorspecific immunity in mice. Oncology
  40. (2004). Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol
  41. (2009). W: Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood
  42. (2004). Y: Cytokines in cancer immunity and immunotherapy. Immunol Rev
  43. (2001). Y: IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFNγ.
  44. (2009). Yoshikai Y: Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4. Int Immunopharmacol
  45. (2009). Zhang HQ: Hypoglycemic effect of the total flavonoid fraction from Folium Eriobotryae. Phytomedicine
  46. (2003). Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature